Acquisitions and Partnerships are Highpoints in Q318
SmartTRAK reports that the US OrthoBio Market (comprised of Bone Replacement, Cartilage, Soft Tissue and Meniscus) is growing at 4.1% YTD. For Q318, there were no surprises and the segment reached...
- Market Overview
- Market Dynamics Continue to Shape the Bone Replacement Segment
- US Stem Cells Segment
- US Bone Growth Factors Segment
- US Synthetics Segment
- US DBM Segment
- US Spinal Constructs
- Strong Performance for US Cartilage Replacement Market
- US Soft Tissue Replacement Segment Softens Slightly
- Challenges Continue for Meniscal Allografts
- Regulatory Approval Highlights Q318
Competition within in the market is propelling companies to be more strategic, leading to partnerships, acquisitions, divestitures and increased investments in product development and commercialization...